- When your AI agent goes off script: What Moffitt Cancer Center caught early
- Utah physician, 2 nurses charged with $29M fraud scheme
- 3 Ascension CFO moves in 2 days
- The volume paradox costing ASCs millions
- Pediatric radiology leaders launch AI brain tumor dataset
- Inside SCA Health’s clinical nursing ladder — and how it helped cut turnover by 7%
- What ASCs are getting wrong about OR delays — and how to fix it
- 1 behavioral health leader’s playbook for staff retention and safety
- Centene executive to join Froedtert ThedaCare as chief nurse
- Behavioral health ED visits projected to rise by 1 million
- UPMC provides free RN-BSN degree to its nurses
- Physicians aren’t buying payers’ prior auth pledge: 5 survey notes
- 5 dental AI updates in 1 month
- 3 lawsuit settlements in dentistry
- Financial pressures shutter Iowa dental clinics: 4 notes
- 4 cities where systems are winning new grads from tech, finance
- Medline launches predictive supply chain platform and 5 more updates to know
- Independent autism research committee adds 7 members
- FDA Commissioner Marty Makary Resigns After Trump Pressure
- 10 notes on the widening DSO performance gap
- Health systems are betting on retail partnerships
- CDC-linked autism researcher arraigned on fraud charges
- Nearly 1 in 3 boys under 14 discussed suicide in crisis conversations: Report
- How anesthesia became a financial liability for ASCs
- 4 pressures converging on pharmacy
- Ascension Texas hospital taps new assistant CFO
- 82% of physicians are now employed: 6 notes
- Atlanta-area medical office portfolio sold in leaseback deal
- New warning sign for sudden cardiac death found: Study
- NAPA partners with New York hospital
- As Trump arrives in China, Big Pharma CEOs are notably absent
- Remarks at the MFA Legal & Compliance 2026 Conference
- GLP-1 Drugs May Improve Breast Cancer Outcomes
- CMS pauses hospice, home health Medicare enrollments in fraud crackdown
- Merck KGaA looks to M&A to bolster its 'rather slim' pipeline
- Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
- BeOne Medicines’ Brukinsa TV ad 'Clarity' hit by FDA over 'misleading suggestions'
- Health systems are exploring AI-powered opportunistic screening. New CMS reimbursement could unlock a business case for it
- Most mental health practitioners satisfied with work, financially stable, SimplePractice finds
- Ted Turner's Brain Disease More Common Than Previously Thought, Review Finds
- Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies
- Ivermectin Prescriptions Doubled After Mel Gibson Cancer Cure Claim
- Haleon tackles sports injuries with latest soccer play
- Eating Out Linked To Obesity Risk Worldwide
- Perimenopausal Women Face Greater Heart Risk, Study Finds
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- RFK Jr. Swaps Vaccine Talk for Healthy Foods and Reading to Tots in Push To Woo Voters
- Trump and Kennedy Seek To Relax Safeguards for AI Healthcare Tools
- Valneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines
- California to award $111M for behavioral health supportive housing
- 6 new psychiatric residency programs to know
- USOSM adds New York practice
- NAMI partners on health crisis preparation hub
- Oklahoma enacts law expanding access to dental care
- Where dentists are leaving value behind in practice sales
- Why dental practices are closing in 2026
- Texas dental school to launch master’s program with orthodontic specialty
- Qualitas Dental Partners makes investments into 7 practices
- Mayo Clinic CEO Gianrico Farrugia stepping down at year's end
- 988 calls are rising — what’s behind the surge?
- Providence hospital to lay off 40 workers amid behavioral health staffing overhaul
- BioMarin consolidates staff at Amicus HQ after closing $4.8B deal for rare disease peer
- US Monitors For Hantavirus As WHO Expects More Cases But 'Not Another COVID'
- University of California, union near May 14 strike deadline with no deal in hand
- 1 in 5 marketplace enrollees dropped their coverage in 2026: media report
- Hims & Hers posts $92M loss in Q1 as it shifts to branded GLP-1 medications
- Listen to the Latest ‘KFF Health News Minute’
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- Providence puts years of losses in rearview with its third consecutive quarter of operating gains
- Millions of Women Suffer in Silence From Treatable Pelvic Organ Prolapse
- Eli Lilly pauses Indian obesity awareness campaign after regulatory notices: report
- Optum Rx unveils new transparent PBM model
- Fitness wearable Whoop adds on-demand clinician access, EHR syncing
- Alkermes’ Lumryz hits phase 3 mark in another sleep disorder, fueling momentum from $2.4B Avadel acquisition
- ACA exchanges take spotlight in Q1
- Bayer's Eylea declines by 24%, bearing the brunt of biosmilar competition
- Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- What's Fueling The High U.S. Death Rate? It Might Not Be What You Think
- Telemedicine Not Breaking The Bank, Also Not Expanding Patient Access
- After-School Sports An Overall Boon To Children And Teens, Study Shows
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up
- Why Are Older Adults Taking Edibles? Survey Reveals Some Surprises
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- EU advances scheme to bolster manufacturing autonomy, avert drug shortages
- Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
- The broken pipeline of mental healthcare for LGBTQ teenagers
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- Is your hospital ready for a prolonged IT outage? Joint Commission, AHA's new resiliency program will let you know
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- Roche acquires PathAI to transform AI-driven diagnostics
- Roche acquires PathAI to transform AI-driven diagnostics
- Trump Planning to Fire FDA Commissioner Marty Makary
- Trump Planning to Fire FDA Commissioner Marty Makary
- Included Health launches AI-powered solution to connect members to providers
- FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer
- The Hidden Design Flaw in Medical Device Service Technology
- The Hidden Design Flaw in Medical Device Service Technology
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- 8,500 Steps A Day Could Be Sweet Spot For Preventing Weight Regain
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Survey: Employers seeking greater transparency from pharmacy benefits
- Kaiser Permanente's investments pick up the slack as Q1 operating margin slims to 2.1%
- AMA unveils policy framework to combat AI deepfake physician impersonation
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion
- Healthcare bankruptcies up 33% in Q1 2026: report
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Older Adults Have Fewer Regrets, Study Says
- Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer
- Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- Nighttime Heat Waves Increase Asthma Risk
- Watch: 8 Health Insurance Terms You Should Know
- As Ranks of Uninsured Grow, Minnesota’s Hospitals Are Among Least Charitable in Nation
- OVID Health hires Edelman alum Davide Scalenghe to boost its international footprint
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Eli Lilly shoots for health in new Caitlin Clark ad campaign
- Omada Health posts 42% revenue jump in Q1, joins Eli Lilly employer weight loss program
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- The Make America Healthy Again Movement Comes for Hospital Food
- Remarks at the Conference on Financial Market Regulation
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Skil-Care launches specialized healthcare product innovation program
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- Remarks at the Special Competitive Studies Project AI+ Expo
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- Integrated CDO capabilities reduce early development complexity
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Workplace safety is a top priority for 93% of healthcare leaders: Axon survey
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- Remarks at the 13th Annual Conference on Financial Market Regulation
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
We've heard enough whiz-bang health reform ideas out of Washington, D.C. to earn the right of cynics everywhere to yawn and go do something effective like washing dishes.
Here Real Clear Policy delivers a Congressional assessment with enough substance, I'm tempted to actually follow it.
We'll see.
The Right Rx on Health Policy: a Strong House Performance
After enacting a pro-patient, pro-consumer health care agenda that could expand personal choices and lower costs, House Speaker Kevin McCarthy (R-CA) and his leadership team deserve credit. From expanding access to affordable health coverage for small businesses to ensuring price transparency for medical services and requiring Medicare to pay the same for certain procedures, whether they are delivered in a hospital setting or a doctor’s office, the Speaker’s targeted approach is starting to bear fruit.
The recently enacted Choice Arrangement Act (H.R. 3799), sponsored by Rep. Kevin Hern (R-OK), is a prime example. Heading to the Senate after being passed by a vote of 220 to 209, Rep. Hern’s bill directly addresses the problems of small businesses and their workers who have no options if they cannot afford the current cost of group employment coverage.
Under the bill, small employers would be able to band together—whether they are in the same industry or not—to create an “association health plan” and a large insurance pool that would empower employers to negotiate lower premiums and out-of- pocket costs for their employees. It would also enable them to customize their benefit offerings, which would reduce employee premium costs.
Rep. Hern’s bill also allows employers to provide individual coverage health reimbursement arrangements (ICHRAs) for their workers. Under these arrangements, employers can make tax-free contributions to special accounts that workers can then use to buy individual health insurance with tax-free premiums. That means that workers and their families would be able to enroll in the kind of health plans that they want, but without companies imposing lifetime caps or denying people coverage for preventive medical services.
Overall, the bill expands private coverage options for workers and businesses—something that the ACA and other government-run health programs fail to do. Perhaps that’s why the National Federation of Independent Business (NFIB), representing small businesses, strongly supports the bill. It certainly helps explain why the Biden administration strongly opposes it.
Meanwhile, in a refreshing break from intense partisan polarization, Rep. Cathy McMorris Rogers (R-WA), chair of the House Energy and Commerce Committee, has been working closely with ranking minority leader Rep. Frank Pallone (D-NJ) to secure bipartisan support for a half dozen health-related bills that will soon be schedule for House floor, debate, and passage.
Perhaps the most significant for patients are the provisions of H.R. 3561, The Patient Act, which reinforces existing regulations related to promoting transparency. More specifically, the bill would require hospitals to publish a consumer-friendly list of the standard charges for a total of 300 shoppable services. The list must include the price for each item and service, including any current payer-specific negotiated charges, the maximum and minimum negotiated prices, and the discounted price. If hospitals fail to comply, they would be subjected to a fine, and the government would publish a list of those hospitals violating the law.
Their bill would also apply price transparency rules to health insurance plans, including plans in the individual market, as well as the small and large group markets. In other words, insurers would be required to provide the public with pricing information on benefits and services, including the in-network rates, the maximum allowed amount, and the amount of cost sharing for each item or service. Price transparency requirements would also apply to clinical laboratory tests, Medicare Advantage plans, Medicare prescription drug plans, and pharmacy benefit managers (PBMs).
This legislation is a good start. A robust price transparency policy could deliver significant health care savings. Writing in Inquiry, the Journal of Health Care Organization, Provision and Financing, Professor Stephen Parente of the University of Minnesota estimates that transparency for hospital and insurance pricing could potentially achieve an annual savings pf $80.7 billion in 2025, resulting in a 6.9 percent reduction medical spending for all privately insured persons. Low-income Americans would enjoy the greatest benefit.
Under Section 302 of The Patient Act, the authors also touch on the anti-competitive payment structure that benefits hospitals over patients. The bill stipulates that Medicare (beneficiaries and federal taxpayers) would pay no more for physician-administered drugs delivered in a hospital setting than in a doctor’s office. This would help establish wider site neutrality in Medicare payment, which would, in turn, start to create a level playing field for serious market competition between giant hospital corporations and independent medical practices. And more competition, of course means lower costs.
All of this would save a lot of money in the healthcare sector. According to a recent study conducted on behalf of the Blue Cross Blue Shield Association, comprehensive Medicare site neutrality would yield a total savings of $471 billion over ten years, including a reduction of $117 billion in private health insurance premiums.
It could also achieve serious financial advantages for consumers on the ground. Writing in JAMA Network, a team of academicians recently examined comparative pricing for a set of shoppable medical procedures delivered by 1116 conventional hospitals and 156 physician-owned hospitals in the same geographic areas. They found that the physician-owned hospitals were able to deliver the same services at prices that were approximately one-third lower than conventional hospitals. A stunning performance.
But there is one big problem: Medicare patients today cannot take full advantage of physician owned hospitals, despite their superior record in providing high quality and cost- effective care. With the Affordable Care Act (ACA), Congress and the Obama administration restricted Medicare and Medicaid reimbursement for these innovative facilities; an anti-competitive measure that undercuts seniors access to high quality and specialized hospital care.
It is past time to reverse this costly and outdated policy. And Congress should build on its recent momentum to turbo-charge its health care price transparency agenda.
One big idea the House should consider to accelerate the impact of price transparency is a “shared savings” program. Simply put, if an insured patient with several options for a medical service chooses a low-cost option, the insurance company would share the savings from that choice, say 50/50, with the patient.
In short, the insurance company would give the patient a tax-free rebate, which he could, if he wished, deposit in a health savings account. Such a program would harness the economic incentives of both patients and health insurers in securing cost- effective care, while intensifying competition among medical professionals in delivering high quality care at competitive prices.
If their record so far is any indication, the 118th Congress is well on its way to making serious progress on health care reform. They deserve credit, and more importantly, they deserve our support. After all, there is still much more to be done.
Robert E. Moffit, PhD., is a Senior Fellow, and Mary McCloskey is a Research Assistant, in the Center for Health and Welfare Studies at The Heritage Foundation.
Morning Brew's take on an earlier congressional hearing about insulin prices.
This article was previously posted in the Following Pharma section header.
"Executives from top insulin makers Eli Lilly and Company, Novo Nordisk, and Sanofi testified alongside the three largest pharmacy benefit managers (PBMs)—CVS Health, Optum Rx, and Express Scripts—in a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing Wednesday over the drug’s increasing prices.
The hearing provided few solutions on how to make insulin more affordable, as the pharma executives and PBMs blamed each other for the high drug prices, echoing arguments made in 2019 that brought the same companies in front of Congress.
“If somebody in the real world is watching this hearing, they have heard every single person from the drug companies and from the PBMs say, ‘We are working tirelessly to lower the cost of prescription drugs, just knocking our brains out.’ And yet, at the end of the day, 1.3 million Americans are rationing their insulin,” HELP Committee Chairman Sen. Bernie Sanders said in the hearing Wednesday.
The insulin makers argued that higher rebate demands from PBMs have pushed list prices up. Drug manufacturers give PBMs rebates in exchange for preferential placement on a health plan’s list of approved medications. For every $1 increase in rebates, the list price of a prescription drug goes up $1.17 on average, according to a 2020 study from the University of Southern California."
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















